Acetate
- Generic Name
- Acetate
- Drug Type
- Small Molecule
- Chemical Formula
- C2H3O2
- CAS Number
- 71-50-1
- Unique Ingredient Identifier
- 569DQM74SC
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 653
- Registration Number
- NCT05505435
- Locations
- 🇺🇸
Family Planning Associates, Chicago, Illinois, United States
Comparing the Hemodynamic Effects of Volume Loading vs Non-loading During Induction of Anesthesia in Fluid Responder Patients With Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Graft Surgery: a Randomized Controlled Study.
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Kasr El Aini Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05462847
- Locations
- 🇪🇬
Kasr Al Ainy, Cairo, Egypt
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Phase 3
- Conditions
- Female Breast CancerAdvanced Breast Cancer
- Interventions
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Ahon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 312
- Registration Number
- NCT05438810
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Phase 2
Recruiting
- Conditions
- Atypical Endometrial HyperplasiaFertility IssuesOverweight and Obesity
- Interventions
- Behavioral: Intensive Lifestyle Intervention (ILI)Drug: Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Xiaojun Chen
- Target Recruit Count
- 172
- Registration Number
- NCT05316493
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Phase 2
Recruiting
- Conditions
- ObeseOverweightFertility IssuesEndometrial Carcinoma
- Interventions
- Behavioral: Intensive Lifestyle Intervention (ILI)
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Xiaojun Chen
- Target Recruit Count
- 89
- Registration Number
- NCT05316467
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Phase 2
Recruiting
- Conditions
- Endometrial Neoplasm Malignant Stage I
- Interventions
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 104
- Registration Number
- NCT05247268
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
Effect of Using Dextrose-containing Intraoperative Fluid in Children
Not Applicable
- Conditions
- Pediatric Surgery
- Interventions
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Mahidol University
- Target Recruit Count
- 68
- Registration Number
- NCT05061836
- Locations
- 🇹🇭
Siriraj Hospital, Bangkok noi, Bangkok, Thailand
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
Phase 2
Completed
- Conditions
- ProstatectomyOligometastatic Prostate CancerAbiraterone
- Interventions
- Procedure: robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissectionDrug: Luteinizing Hormone-Releasing Hormone Analog
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Target Recruit Count
- 130
- Registration Number
- NCT04992026
- Locations
- 🇨🇳
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 12
- Registration Number
- NCT04795856
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
Phase 1
Completed
- Conditions
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 19
- Registration Number
- NCT04711486
- Locations
- 🇩🇪
Charité University Medicine, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath